Progression of chronic kidney disease in non- dialysis patients: a retrospective cohort

Progression of chronic kidney disease in non- dialysis patients: a retrospective cohort

Abstract Evidence on factors associated with the progression of chronic kidney disease (CKD) is still under construction. The present study aimed to evaluate sociodemographic, clinical, and drug use factors associated with the progression of CKD. A retrospective cohort study was conducted with 193 p...

Full description

Bibliographic Details
Main Authors:	Jéssica Azevedo Aquino, Cláudia Lorenzo Oliveira, Alba Otoni, Cristina Sanches, João Victor Marques Guedes, Diego Bruno Morais, Thays Santos Mendonça, Flávio Augusto Morais, André Oliveira Baldoni
Format:	Article
Language:	English
Published:	Universidade de São Paulo 2022-11-01
Series:	Brazilian Journal of Pharmaceutical Sciences
Subjects:	Chronic kidney disease Disease progression Drug utilization Drug therapy Nephrology
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502022000100736&lng=en&tlng=en

Similar Items

Opportunistic peritonitis in peritoneal dialysis: The example of Paracoccus yeei
by: Christelle Fosso, et al.
Published: (2021-05-01)

When kidneys get old: an essay on nephro-geriatrics
by: Richard Glassock, et al.

Trichodysplasia spinulosa post kidney transplant
by: Franco Cabeza Rivera, et al.
Published: (2024-11-01)

Benefits of Aldosterone Receptor Antagonism in Chronic Kidney Disease (BARACK D) trial–a multi-centre, prospective, randomised, open, blinded end-point, 36-month study of 2,616 patients within primary care with stage 3b chronic kidney disease to compare the efficacy of spironolactone 25 mg once daily in addition to routine care on mortality and cardiovascular outcomes versus routine care alone: study protocol for a randomized controlled trial
by: Hill, NR, et al.
Published: (2014)

Longitudinal biomarkers and kidney disease progression after acute kidney injury
by: Yumeng Wen, et al.
Published: (2023-05-01)

International Nephrology Masterclass in Chronic Kidney Disease: Rationale, Summary, and Future Perspectives
by: Francesco Pesce, et al.
Published: (2024-12-01)

Reliability and Validation of MSCEIT to Evaluate Emotional Intelligence for Chronic Kidney Disease Patients
by: Kogila Supramanian, et al.
Published: (2024-01-01)

Endogenous adenine mediates kidney injury in diabetic models and predicts diabetic kidney disease in patients
by: Kumar Sharma, et al.
Published: (2023-10-01)

Iron therapy mitigates chronic kidney disease progression by regulating intracellular iron status of kidney macrophages
by: Edwin Patino, et al.
Published: (2023-01-01)

Tubular cell senescence promotes maladaptive kidney repair and chronic kidney disease after cisplatin nephrotoxicity
by: Siyao Li, et al.
Published: (2023-04-01)

Electrophoretic analysis (sds-page) of canine urinary proteins according to the stage of chronic kidney disease
by: L.T. Patitucci, et al.
Published: (2020-08-01)

Did a reform strategy in drug management improve doctors’ prescribing habits in Montenegro: The example for the cardiovascular drugs
by: Duborija-Kovačević Nataša, et al.
Published: (2006-01-01)

Establishing kidney transplantation in a low-income country: a case in Tanzania
by: Francis F. Furia, et al.
Published: (2024-05-01)

Snapshots of nascent RNA reveal cell- and stimulus-specific responses to acute kidney injury
by: Tian Huai Shen, et al.
Published: (2022-03-01)

Screeing of Patients with Essential Hypertension as a Prevention Method Hypertensive Nephropathy
by: M. M. Batyushin, et al.
Published: (2012-03-01)

Endocapillary proliferative glomerulonephritis associated with Q fever endocarditis: A case report
by: Craig Peter Coorey, et al.
Published: (2024-10-01)

Dicarbonyl-modified lipoproteins contribute to proteinuric kidney injury
by: Jianyong Zhong, et al.
Published: (2022-11-01)

Assessment of kidney proximal tubular secretion in critical illness
by: Pavan K. Bhatraju, et al.
Published: (2021-05-01)

Renal tubular peroxisomes are dispensable for normal kidney function
by: Camille Ansermet, et al.
Published: (2022-02-01)

Deep learning–based molecular morphometrics for kidney biopsies
by: Marina Zimmermann, et al.
Published: (2021-04-01)

Immune checkpoint activity regulates polycystic kidney disease progression
by: Emily K. Kleczko, et al.
Published: (2023-06-01)

Calponin 2 regulates ketogenesis to mitigate acute kidney injury
by: Yuan Gui, et al.
Published: (2023-11-01)

Identifying cell-enriched miRNAs in kidney injury and repair
by: Katie L. Connor, et al.
Published: (2020-12-01)

Muscle fibrosis and maladaptation occur progressively in CKD and are rescued by dialysis
by: Camille R. Brightwell, et al.
Published: (2021-12-01)

Low nephron endowment increases susceptibility to renal stress and chronic kidney disease
by: Pamela I. Good, et al.
Published: (2023-02-01)

Ciclopirox olamine induces ferritinophagy and reduces cyst burden in polycystic kidney disease
by: Priyanka S. Radadiya, et al.
Published: (2021-04-01)

The European Rare Kidney Disease Registry (ERKReg): objectives, design and initial results
by: Giulia Bassanese, et al.
Published: (2021-06-01)

Lab-based and diagnosis-based chronic kidney disease recognition and staging concordance
by: Clarissa J. Diamantidis, et al.
Published: (2019-09-01)

Kidney collecting duct cells make vasopressin in response to NaCl-induced hypertonicity
by: Juan Pablo Arroyo, et al.
Published: (2022-12-01)

JAML promotes acute kidney injury mainly through a macrophage-dependent mechanism
by: Wei Huang, et al.
Published: (2022-07-01)

Remote effects of kidney drug transporter OAT1 on gut microbiome composition and urate homeostasis
by: Vladimir S. Ermakov, et al.
Published: (2023-11-01)

Restoration of proximal tubule flow–activated transport prevents cyst growth in polycystic kidney disease
by: Zhaopeng Du, et al.
Published: (2021-05-01)

The molecular chaperone GRP170 protects against ER stress and acute kidney injury in mice
by: Aidan W. Porter, et al.
Published: (2022-03-01)

Proximal tubular epithelial insulin receptor mediates high-fat diet–induced kidney injury
by: Hak Joo Lee, et al.
Published: (2021-02-01)

The tryptophan-metabolizing enzyme indoleamine 2,3-dioxygenase 1 regulates polycystic kidney disease progression
by: Dustin T. Nguyen, et al.
Published: (2023-01-01)

Mitochondrial and NAD+ metabolism predict recovery from acute kidney injury in a diverse mouse population
by: Jean-David Morel, et al.
Published: (2023-02-01)

Inhibition of retinoic acid signaling in proximal tubular epithelial cells protects against acute kidney injury
by: Min Yang, et al.
Published: (2023-10-01)

Integration of spatial and single-cell transcriptomics localizes epithelial cell–immune cross-talk in kidney injury
by: Ricardo Melo Ferreira, et al.
Published: (2021-06-01)

Blocking cell cycle progression through CDK4/6 protects against chronic kidney disease
by: Yosuke Osaki, et al.
Published: (2022-06-01)

BAM15 treats mouse sepsis and kidney injury, linking mortality, mitochondrial DNA, tubule damage, and neutrophils
by: Naoko Tsuji, et al.
Published: (2023-04-01)